More than 2.5 million bottles of Prednisolone Acetate Ophthalmic Suspension eye drops were recalled because of the potential presence of a foreign substance, according to the FDA’s enforcement report. Lupin Pharmaceuticals Inc. manufactured the drops.
The recall was initiated June 4 but was classified as a Class II recall June 30, according to the enforcement report. The FDA said a Class II recall applies to products that, if used or exposed to, may cause temporary or medically reversible adverse health consequences.
Other recently recalled Eye Drops include the following:
